# Spatial Distribution of K13-Positive Airway Epithelial Cells in Idiopathic Pulmonary Fibrosis

**Authors:** Fei Teng, Qi Zheng, Yansong Bai, Qianqian Zhao, Yanghe Fu, Huiqi Dai, Chenwen Huang, Tao Ren

PMC · DOI: 10.3390/biomedicines14030728 · Biomedicines · 2026-03-23

## TL;DR

This study shows that K13+ cells in the lungs of IPF patients become active and contribute to disease progression by changing the airway structure and signaling with other cells.

## Contribution

The study identifies K13+ cell activation as a key driver of airway proximalization and fibrosis in IPF.

## Key findings

- K13+ cells in IPF lungs show a proximal-like pseudostratified phenotype with overlapping expression of K5, CC10, ACE-TUB, and MUC5AC.
- K13+ subclusters are associated with profibrotic markers and signaling pathways like TGF-β and SEMA3.
- K13+ cell activation is linked to epithelial-mesenchymal crosstalk and airway remodeling in IPF.

## Abstract

Background: The progression of idiopathic pulmonary fibrosis (IPF) involves distal airway remodeling and bronchiolization; however, the mechanisms driving these changes, particularly the contributions of epithelial stem cells, are not fully understood. K13+ hillock cells, normally quiescent in proximal airways, were examined for their potential contribution to IPF pathogenesis. Methods: Spatial immunofluorescence was used to profile K13 expression along the airway axes in IPF and control lungs. Multiplex staining complemented by ex vivo culture assays was used to test expression stability. Single-cell RNA-sequencing (scRNA-seq) data were re-analyzed to identify cell subclusters and pathway enrichments. Meanwhile, cell–cell communication was inferred by using CellChat. Results: K13 was ectopically upregulated in IPF honeycomb cysts, triggering a proximal-like pseudostratified phenotype. This shift was marked by surges in K13+ regionally overlapping expression patterns (K5+, ~9%; CC10+, ~53%; ACE-TUB+, ~44%; MUC5AC+, ~23%) and a decline in SOX2 expression (~95% to ~64%), with ~70% of residual SOX2low cells exhibiting elevated K13. Accompanying the expansion of K13+ subclusters (basal: 1.8% to 41.5%; club: 10.7% to 31.5%), it was observed that the profibrotic markers (K17, S100A2, LGALS7, IGFBP6) and ontologies related to RNA processing, stress response, and senescence were also enriched. These subclusters also amplified pro-fibrotic signaling (e.g., TGF-β, SEMA3, and GALECTIN-9) associated with epithelial subtypes and HAS1high fibroblasts. Conclusions: Here, we demonstrate that K13+ cell activation is a pivotal event, driving the dysregulated proximalization of distal airways in IPF through fate reprogramming and epithelial-mesenchymal crosstalk. Thus, elucidating these K13-mediated fate dynamics provides a critical framework for understanding IPF pathogenesis.

## Linked entities

- **Genes:** KCNG1 (potassium voltage-gated channel modifier subfamily G member 1) [NCBI Gene 3755], KRT5 (keratin 5) [NCBI Gene 3852], SCGB1A1 (secretoglobin family 1A member 1) [NCBI Gene 7356], MUC5AC (mucin 5AC, oligomeric mucus/gel-forming) [NCBI Gene 4586], SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657], KRT17 (keratin 17) [NCBI Gene 3872], S100A2 (S100 calcium binding protein A2) [NCBI Gene 6273], LGALS7 (galectin 7) [NCBI Gene 3963], IGFBP6 (insulin like growth factor binding protein 6) [NCBI Gene 3489], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], Lgals9 (lectin, galactose binding, soluble 9) [NCBI Gene 16859], HAS1 (hyaluronan synthase 1) [NCBI Gene 3036]
- **Diseases:** idiopathic pulmonary fibrosis (MONDO:0800029), IPF (MONDO:0800504)

## Full-text entities

- **Genes:** KRT13 (keratin 13) [NCBI Gene 3860] {aka CK13, K13, WSN2}, LGALS9 (galectin 9) [NCBI Gene 3965] {aka HUAT, LGALS9A}, SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657] {aka ANOP3, MCOPS3}, SCGB1A1 (secretoglobin family 1A member 1) [NCBI Gene 7356] {aka CC10, CC16, CCPBP, CCSP, UGB, UP-1}, IGFBP6 (insulin like growth factor binding protein 6) [NCBI Gene 3489] {aka IBP6}, KRT17 (keratin 17) [NCBI Gene 3872] {aka 39.1, CK-17, K17, PC2, PCHC1}, S100A2 (S100 calcium binding protein A2) [NCBI Gene 6273] {aka CAN19, S100L}, MUC5AC (mucin 5AC, oligomeric mucus/gel-forming) [NCBI Gene 4586] {aka MUC5, TBM, leB, mucin}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, LGALS7 (galectin 7) [NCBI Gene 3963] {aka GAL7, LGALS7A}
- **Diseases:** IPF (MESH:D054990)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024621/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024621/full.md

## References

79 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024621/full.md

---
Source: https://tomesphere.com/paper/PMC13024621